Download presentation
Presentation is loading. Please wait.
1
Volume 74, Issue 1, Pages 17-23 (July 2018)
The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score Kurt Miller, Joan Carles, Jürgen E. Gschwend, Hendrik Van Poppel, Joris Diels, Sabine D. Brookman-May European Urology Volume 74, Issue 1, Pages (July 2018) DOI: /j.eururo Copyright © 2017 European Association of Urology Terms and Conditions
2
Fig. 1 CONSORT study flow diagram. CONSORT=Consolidated Standards of Reporting Trials; ITT=intention to treat. European Urology , 17-23DOI: ( /j.eururo ) Copyright © 2017 European Association of Urology Terms and Conditions
3
Fig. 2 Kaplan–Meier analysis of time-to-event end points with abiraterone acetate plus prednisone and prednisone: (A) overall survival; (B) radiographic progression-free survival. (C) time to chemotherapy; and (D) time to opiate use. AA=abiraterone acetate; P=prednisone. European Urology , 17-23DOI: ( /j.eururo ) Copyright © 2017 European Association of Urology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.